Gestão de Antimicrobianos

M-A | Fatores de risco para pneumonia adquirida por Stenotrophomonas maltophilia na UTI.

29 Abr, 2022 | 14:44h

Risk Factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: A Systematic Review and Meta-Analysis – Frontiers in Medicine

---

Revisão | Uso de antibióticos para infecções de corrente sanguínea na UTI.

28 Abr, 2022 | 11:44h

Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review – Antibiotics

---

Consenso sobre o tratamento da tinea pedis.

27 Abr, 2022 | 16:22h

Consensus for the Treatment of Tinea Pedis: A Systematic Review of Randomised Controlled Trials – Journal of Fungi

---

Diretriz de especialistas | Estratégias para prevenir infecções de corrente sanguínea por cateter central em hospitais de cuidado agudo.

21 Abr, 2022 | 12:41h

Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update – Infection Control & Hospital Epidemiology

 

Comentário no Twitter

Prevention of central line-associated bloodstream infections in acute-care hospitals- 2022 updatehttps://t.co/o3AReYvJIu pic.twitter.com/QsgYYezhqj

— K Pavithran (@drkpavithran) April 19, 2022

Artigo sob licença de http://creativecommons.org/licenses/by/4.0/

---

Diretriz AAOS | Prevenção de infecções em sítio cirúrgico após trauma extenso em extremidades.

21 Abr, 2022 | 11:46h

Prevention of Surgical Site Infections After Major Extremity Trauma: Evidence-Based Clinical Practice Guideline – American Academy of Orthopaedic Surgeons

Revisão de evidência: Prevention of Surgical Site Infection After Extremity Trauma (2022)

---

Estudo randomizado | Regime de 12 meses de itraconazol oral é superior ao regime de 6 meses no tratamento para evitar recidivas de aspergilose pulmonar crônica.

19 Abr, 2022 | 12:43h

Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India – The Lancet Infectious Diseases (link para o resumo – $ para o texto completo)

---

Diretrizes para o monitoramento terapêutico medicamentoso da vancomicina.

19 Abr, 2022 | 12:37h

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring – Pharmaceutics

Diretriz relacionada:

Diretriz: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Resumo: Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists – Clinical Infectious Diseases

 

Comentário no Twitter

🔔Rings Cowbell🔔
New Vancomycin guidelines drop from Japan.

This is the most written about the need for #PrecisionDosing that I have seen.

Give patients the dose they need because #OneSizeFitsNone@SIDPharm @ABsteward @IDstewardship https://t.co/wlwgkqZmXu

— Marc H. Scheetz (@IDPharmacometrx) April 13, 2022

 

---

Estudo de coorte multicêntrico | Diarreia durante doença crítica.

19 Abr, 2022 | 12:35h

Diarrhea during critical illness: a multicenter cohort study – Intensive Care Medicine

 

Comentário no Twitter

Diarrhea in #ICU
➡️common but variable incidence (definition applied)
➡️rarely caused by Clostridioides difficile
➡️modifiable predictors include EN/duration of ABs exposure
➡️associated with longer time to discharge but not increased mortality#FOAMcc
📖 https://t.co/Wx0T7RWukV pic.twitter.com/CvhWgTEwJb

— Intensive Care Medicine (@yourICM) April 14, 2022

 

---

Validação prospectiva de um teste rápido de expressão gênica do hospedeiro para diferenciar infecção respiratória bacteriana de viral.

19 Abr, 2022 | 12:20h

Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection – JAMA Network Open

 

Comentário no Twitter

In this diagnostic study, a new host gene expression test identified patients unlikely to have bacterial infection in only 45 minutes, a potential new tool for antibiotic stewardship. https://t.co/3JiYl2N4b0

— JAMA Network Open (@JAMANetworkOpen) April 14, 2022

 

---

Risco de transmissão domiciliar assintomática de infecção por Clostridioides difficile associada com internação recente de membros da família.

19 Abr, 2022 | 12:13h

Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members – Emerging Infectious Diseases

Comentário: Recently Discharged Patients Pose Risk for Spreading C. Difficile Infection – HealthDay

---